Tyche Industries Ltd. | Small-cap | Healthcare
₹135.00
-0.63%
| Tyche Industries Stock Comparison:
Tyche Industries vs Sun PharmaceuticalTyche Industries vs Divi's LaboratoriesTyche Industries vs Sun Pharma AdvancedTyche Industries vs Aarti DrugsTyche Industries vs Sequent ScientificTyche Industries vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 123.7M
Gross Profit 69.5M 56.19%
Operating Income -6.8M -5.46%
Net Income 9.4M 7.63%

Balance Sheet Metrics

Total Assets 1.5B
Total Liabilities 107.1M
Shareholders Equity 1.4B
Debt to Equity 0.08

Cash Flow Metrics

Revenue & Profitability Trend

Tyche Industries Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i654.7M695.1M753.9M622.7M782.4M
Cost of Goods Sold i248.3M410.5M433.8M367.2M395.3M
Gross Profit i406.4M284.6M320.0M255.4M387.1M
Gross Margin % i62.1%40.9%42.5%41.0%49.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-45.7M50.3M50.6M40.4M
Other Operating Expenses i197.5M13.9M14.0M11.2M7.6M
Total Operating Expenses i197.5M59.6M64.2M61.8M48.0M
Operating Income i93.0M108.8M145.9M99.0M241.5M
Operating Margin % i14.2%15.7%19.4%15.9%30.9%
Non-Operating Items
Interest Income i-50.5M36.9M30.4M29.2M
Interest Expense i15.0K00069.0K
Other Non-Operating Income-----
Pre-tax Income i167.1M166.3M190.8M126.4M267.3M
Income Tax i43.1M43.9M49.1M33.0M67.5M
Effective Tax Rate % i25.8%26.4%25.7%26.2%25.3%
Net Income i124.1M122.4M141.7M93.3M199.8M
Net Margin % i19.0%17.6%18.8%15.0%25.5%
Key Metrics
EBITDA i187.0M185.7M209.8M123.4M294.5M
EPS (Basic) i-₹11.95₹13.83₹9.11₹19.51
EPS (Diluted) i-₹11.95₹13.83₹9.11₹19.51
Basic Shares Outstanding i-10245000102450001024500010245000
Diluted Shares Outstanding i-10245000102450001024500010245000

Income Statement Trend

Tyche Industries Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i39.8M39.7M67.2M35.9M73.0M
Short-term Investments i802.8M718.0M625.7M621.9M522.8M
Accounts Receivable i171.2M191.2M220.8M164.2M171.3M
Inventory i166.4M125.6M179.7M112.4M109.5M
Other Current Assets29.2M1.0K71.2M1.0K-1.0K
Total Current Assets i1.2B1.1B1.1B1.0B963.2M
Non-Current Assets
Property, Plant & Equipment i164.8M63.8M53.6M53.2M51.4M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets1.4M20.0M2.7M-18.6M99.0K
Total Non-Current Assets i264.7M238.5M242.7M192.4M206.3M
Total Assets i1.5B1.4B1.4B1.2B1.2B
Liabilities
Current Liabilities
Accounts Payable i58.0M38.3M123.8M59.0M68.8M
Short-term Debt i-000-
Current Portion of Long-term Debt-----
Other Current Liabilities15.0M9.7M1.0K21.1M17.8M
Total Current Liabilities i96.2M66.8M165.7M128.3M177.9M
Non-Current Liabilities
Long-term Debt i00000
Deferred Tax Liabilities i10.8M11.7M12.4M13.6M14.5M
Other Non-Current Liabilities-2.0K-1.0K18.6M17.5M
Total Non-Current Liabilities i10.8M34.8M33.9M32.2M32.0M
Total Liabilities i107.1M101.6M199.6M160.5M209.9M
Equity
Common Stock i102.5M102.5M102.5M102.5M102.5M
Retained Earnings i-1.1B994.2M870.8M791.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.4B1.3B1.2B1.0B959.6M
Key Metrics
Total Debt i00000
Working Capital i1.1B1.1B958.7M882.0M785.3M

Balance Sheet Composition

Tyche Industries Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i168.2M163.9M189.5M127.3M265.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-14.5M43.5M-130.0M21.6M-51.5M
Operating Cash Flow i93.3M157.0M22.5M118.5M184.6M
Investing Activities
Capital Expenditures i-7.0M-32.3M-17.5M-9.9M-25.0M
Acquisitions i-----
Investment Purchases i-59.6M--50.7M--
Investment Sales i-21.2M---
Investing Cash Flow i-66.6M-11.1M-68.2M1.2M-25.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-25.6M-20.5M-15.4M-10.2M-10.2M
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-25.6M-20.5M-30.7M-20.5M-20.5M
Free Cash Flow i78.2M44.8M46.8M34.7M129.5M
Net Change in Cash i1.1M125.4M-76.4M99.2M139.1M

Cash Flow Trend

Tyche Industries Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 10.81
Forward P/E 23.36
Price to Book 0.93
Price to Sales 2.11
PEG Ratio 23.36

Profitability Ratios

Profit Margin 18.95%
Operating Margin -5.46%
Return on Equity 9.42%
Return on Assets 4.09%

Financial Health

Current Ratio 12.57
Debt to Equity 0.00
Beta 0.20

Per Share Data

EPS (TTM) ₹12.49
Book Value per Share ₹144.76
Revenue per Share ₹64.33

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
tyche1.4B10.810.939.42%18.95%0.00
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.4210.8814.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.4B23.593.2512.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.